The overall OR showed that the frequency of anti-MDA5 antibodies in patients with DM was significantly higher than in healthy controls (OR = 10.49, 95% CI: 4.26–25.81, P < 0.001) (Figure 2). This evidence concerns the gene IFIH1 and dermatomyositis.